Biocompatibility evaluation of dura mater substitutes in an animal model

被引:61
作者
Barbolt, TA
Odin, M
Léger, M
Kangas, L
Holste, J
Liu, SH
机构
[1] Ethicon Inc, Div Res & Dev, Somerville, NJ USA
[2] Merck Chibret, Riom, France
[3] ClinTrials BioRes Ltd, Senneville, PQ, Canada
[4] Ethicon GmbH, Norderstedt, Germany
关键词
dura mater substitute; neurologic; absorbable; tissue reaction; animal model;
D O I
10.1179/016164101101199405
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dura-Guard (R) Dural Repair Patch, PRECLUDE (R) Dura Substitute, and Codman (R) ETHISORB (TM) Dura Patch were evaluated in a six-month dural tissue reaction study in rabbits. Bilateral craniotomy was followed by subdural implantation for each dura mater substitute. The surgical procedure for the sham control group was the same except that no material was implanted. Implantation of all of these dura mater substitutes for 28, 91, or 182 days post-implantation did not result in any deaths or clinical neurobehavioral abnormalities, changes in cerebrospinal fluid, or significant macroscopic changes at necropsy. However, histomorphologic evaluation of the implantation sites revealed some differences in the tissue response to these materials. For Dura-Guard Dural Repair Patch, a nonabsorbable material derived from bovine pericardium, the implantation site was characterized by fibrosis of the overlying area with islands of osseous metaplasia and adhesions to the brain surface. Over time, infiltrative fibrosis of the implant resulted in separation of the collagenous layers of the implant and compression of the underlying brain. Fibrosis of the overlying area that incorporated this material formed a 'replacement' dura mater. Adhesions to the brain surface observed initially were still present at six months post-implantation. Implantation of PRECLUDE Dura Substitute, a nonabsorbable material comprised of expanded polytetrafluoroethylene, resulted in virtually no early reaction, and few adhesions to the brain surface at any time period. Although this material was eventually incorporated by fibrosis, islands of osseous metaplasia were also observed in this 'replacement' dura mater. The tissue reaction to Codman ETHISORB Dura Patch, an absorbable material comprised of polyglactin 910 and polydioxanone, was generally characterized by low-grade granulomatous inflammation and initial adhesions to the brain surface. The three-dimensional structure of this implant acted as a scaffold to guide the development and integration of a 'replacement' dura mater. The absorption of the material was associated with complete resolution of the inflammatory reaction, a lack of cerebral adhesions, and restoration of the normal architecture of this region. In conclusion, subdural implantation of Dura-Guard Dural Repair Patch, PRECLUDE Dura Substitute, or Codman ETHISORB Dura Patch in rabbits for up to six months resulted in the eventual restoration of the dura mater without significant adverse effects. However, osseous metaplasia associated with nonabsorbable Dura-Guard Dural Repair Patch and PRECLUDE Dura Substitute, and the infiltration of Dura-Guard Dural Repair Patch by fibrosis suggests that long-term follow-up may be needed after the use of these materials in patients. An advantage of Codman ETHISORB Dura Patch was that it was completely absorbed after guiding the restoration of the dura mater without any morphological sequelae.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 50 条
  • [1] An alginate hydrogel dura mater replacement for use with intracortical electrodes
    Nunamaker, Elizabeth A.
    Kipke, Daryl R.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2010, 95B (02) : 421 - 429
  • [2] Preparation and characterization of a novel acellular swim bladder as dura mater substitute
    Li, Qing
    Zhang, Fenghua
    Wang, Hongmei
    Pan, Tao
    NEUROLOGICAL RESEARCH, 2019, 41 (03) : 242 - 249
  • [3] Trigeminal activation patterns evoked by chemical stimulation of the dura mater in rats
    Klaudia Flóra Laborc
    Eleonóra Spekker
    Zsuzsanna Bohár
    Mónika Szűcs
    Gábor Nagy-Grócz
    Annamária Fejes-Szabó
    László Vécsei
    Árpád Párdutz
    The Journal of Headache and Pain, 2020, 21
  • [4] Trigeminal activation patterns evoked by chemical stimulation of the dura mater in rats
    Laborc, Klaudia Flora
    Spekker, Eleonora
    Bohar, Zsuzsanna
    Szucs, Monika
    Nagy-Grocz, Gabor
    Fejes-Szabo, Annamaria
    Vecsei, Laszlo
    Pardutz, Arpad
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
  • [5] Characterization of the inflammatory response to four commercial bone graft substitutes using a murine biocompatibility model
    Markel, David C.
    Guthrie, S. Trent
    Wu, Bin
    Song, Zheng
    Wooley, Paul H.
    JOURNAL OF INFLAMMATION RESEARCH, 2012, 5 : 13 - 18
  • [6] Correction of coronal suture synostosis using suture and dura mater allografts in rabbits with familial craniosynostosis
    Mooney, MP
    Burrows, AM
    Smith, TD
    Losken, HW
    Opperman, LA
    Dechant, J
    Kreithen, AM
    Kapucu, R
    Cooper, GM
    Ogle, RC
    Siegel, MI
    CLEFT PALATE-CRANIOFACIAL JOURNAL, 2001, 38 (03) : 206 - 225
  • [7] Topiramate Inhibits Capsaicin-Induced Mast Cell Degranulation and CGRP Release in Rat Dura Mater
    Costa, Raisa Ferreira
    Rosas, Emanuela Paz
    Paz, Silvania Tavares
    de Freitas, Manuela Figueiroa Lyra
    de Souza, Sandra Lopes
    de Andrade, Juliana Ramos
    de Oliveira, Daniella Araujo
    Jansen-Olesen, Inger
    Christensen, Sarah Louise
    Valenca, Marcelo Moraes
    BRAIN SCIENCES, 2024, 14 (11)
  • [8] Evaluation of reward processes in an animal model of depression
    Slattery, David A.
    Markou, Athina
    Cryan, John F.
    PSYCHOPHARMACOLOGY, 2007, 190 (04) : 555 - 568
  • [9] Animal model of undernutrition for the evaluation of drug pharmacokinetics
    Merino-Sanjuan, M.
    Catalan-Latorre, A.
    Nacher, A.
    Miralles-Arnau, S.
    Jimenez-Torres, N. V.
    NUTRICION HOSPITALARIA, 2011, 26 (06) : 1296 - 1304
  • [10] BEHAVIOURAL EVALUATION OF A TRANSLATIONAL ANIMAL MODEL OF SCHIZOPHRENIA
    Cordero, N.
    Muguruza, C.
    Perez-Palomar, B.
    Munarriz-Cuezva, E.
    Javier Meana, J.
    Ortega, J. E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 59 - 59